期刊文献+

鼻咽癌的误诊因素分析及对策 被引量:7

Factor Analysis for Misdiagnosis of Nasopharyngeal Carcinoma and Relevant Countermeasures
暂未订购
导出
摘要 目的:探讨鼻咽癌的误诊原因及对策。方法:对416例初治的鼻咽癌患者的临床资料进行回顾性分析。结果:总误诊率42%,前3位的误诊疾病分别为中耳炎、鼻(窦)炎和颈部淋巴结炎。中位延误诊断时间为3(0~60)个月,其中患者原因及医源性原因各占一半。首发症状、初诊医院等级及科室是影响医源性诊断延迟的重要因素。结论:鼻咽癌较高的初诊误诊率与非鼻咽相关症状、初诊为乡镇医院及非耳鼻喉科就诊相关。普及鼻咽癌知识、加强医生继续教育及采取适当的奖罚机制可能有助于降低鼻咽癌的误诊率。 Objective: This work aims to explore the cause and countermeasures of misdiagnosis of nasopharyngeal carcinoma (NPC). Methods: The naive NPC patients diagnosed in Zhejiang Cancer Hospital in 2011 (from January 1 st to December 31 st) were enrolled in this study. The patients' medical records were retrospectively reviewed and analyzed. Results: Up to 416 cases were involved in the study. The misdiagnosis rate was 42%. The medial delay time in diagnosis was three months (range: 0 - 60), in which patient-related factors equally contributed to the iatrogenic factors for the diagnosis delay. Initial symptoms, the levels of the hospitals, and related divisions for preliminary diagnosis were important factors that influenced misdiagnosis. Conclusions: NPC patients suffer from high misdiagnosis rate, which is related to non-specific symptoms of the nasopharynx, low-level hospitals in small towns, and visiting wrong divisions that are usually not special departments of otorhinolaryngology. Improving people's awareness of NPC, intensifying continuous medical education of doctors, and establishing a reward and punishment system may reduce misdiagnosis of the cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第24期2026-2028,2035,共4页 Chinese Journal of Clinical Oncology
关键词 鼻咽癌 误诊 分析 Nasophapharyngeal carcinoma Misdiagnosis Analysis
  • 相关文献

参考文献13

二级参考文献41

共引文献64

同被引文献78

  • 1应倩,罗湘涛.浙江省肿瘤医院住院疾病谱分析[J].肿瘤防治研究,2004,31(9):590-592. 被引量:10
  • 2余亚明,杨发斌,和变枝.急慢性鼻窦炎误诊586例临床分析[J].临床医学,2006,26(9):87-88. 被引量:2
  • 3任爱军.淋巴结转移癌36例误诊为颈淋巴结炎[J].临床误诊误治,2007,20(2):50-50. 被引量:2
  • 4Uzel EK, Karacam S, Elicin O, et al. Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma[J]. Strahlentherapie und Onkologie, 2013, 189(7):552- 558.
  • 5Dechaphunkul T, Pruegsanusak K, Sangthawan D, et al. Concurrent ehemoradiotherapy with earboplatin followed by earboplatin and 5-fluorouraeil in locally advanced nasopharyngeal carcinoma [J]. Head Neck Oneol, 2011, 3:30.
  • 6Sun Y, Zhou GQ, Qi ZY, et al. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis [J]. BMC Cancer, 2013, 13(1):1-9.
  • 7Wong FC,Ng AW,Lee VH, et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasophm-yngeal carcinoma[J]. Int J Radiat Oneol Biol Phys, 2010,76(1):138-145.
  • 8Wang J, Yang J, Li BB, et al. High cytoplasmic expression of the orphan nuclear receptor NR4A2 predicts poor survival in uasopharyngeal carcinoma[J]. Asian Pacific Journal of Cancer Prevention, 2013, 14(5):2805-2809.
  • 9Niu X, Hu C, Kong L. Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139(6):1063-1071.
  • 10Bonner JA,Harari PM,Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: S-year survival data from a phase 3 randomised trial,and rdatinn between cetuximab-induced rash and survival[J]. Incet Oncol, 2010,11(1):21-28.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部